These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30858027)
1. Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors. Yang X; Cai S; Liu X; Chen P; Zhou J; Zhang H Bioorg Med Chem; 2019 Apr; 27(8):1605-1618. PubMed ID: 30858027 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors. Cai S; Yang X; Chen P; Liu X; Zhou J; Zhang H Bioorg Chem; 2020 Jan; 94():103356. PubMed ID: 31785855 [TBL] [Abstract][Full Text] [Related]
3. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors. Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors. Dong J; Pan X; Yang Y; Zhang G; Xiao Z; Liu Z Eur J Med Chem; 2021 Nov; 223():113631. PubMed ID: 34147748 [TBL] [Abstract][Full Text] [Related]
5. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors. Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors. Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990 [TBL] [Abstract][Full Text] [Related]
8. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors. Gao D; Li Y Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors. Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase. Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory investigation of niacin derivatives on metalloenzyme indoleamine 2,3-dioxygenase 1 for its immunomodulatory function. Yan D; Xu J; Tan X Metallomics; 2021 Feb; 13(3):. PubMed ID: 33638642 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors. Cui G; Lai F; Wang X; Chen X; Xu B Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors. Zhou C; Lai F; Sheng L; Chen X; Li Y; Feng Z Molecules; 2020 Mar; 25(6):. PubMed ID: 32210078 [TBL] [Abstract][Full Text] [Related]
14. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity. Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359 [TBL] [Abstract][Full Text] [Related]
15. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties. Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388 [TBL] [Abstract][Full Text] [Related]
17. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents. Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673 [TBL] [Abstract][Full Text] [Related]
18. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1. Peng YH; Ueng SH; Tseng CT; Hung MS; Song JS; Wu JS; Liao FY; Fan YS; Wu MH; Hsiao WC; Hsueh CC; Lin SY; Cheng CY; Tu CH; Lee LC; Cheng MF; Shia KS; Shih C; Wu SY J Med Chem; 2016 Jan; 59(1):282-93. PubMed ID: 26642377 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of flavonoids isolated from Kwon M; Ko SK; Jang M; Kim GH; Ryoo IJ; Son S; Ryu HW; Oh SR; Lee WK; Kim BY; Jang JH; Ahn JS J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1481-1488. PubMed ID: 31423846 [TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A. Dolušić E; Larrieu P; Meinguet C; Colette D; Rives A; Blanc S; Ferain T; Pilotte L; Stroobant V; Wouters J; Van den Eynde B; Masereel B; Delfourne E; Frédérick R Bioorg Med Chem Lett; 2013 Jan; 23(1):47-54. PubMed ID: 23218716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]